Changes

|-

| 2007 || || Expansion || SCI program starts in Burundi.<ref name="OUR REACH">{{cite web |title=OUR REACH |url=https://www.schistosomiasiscontrolinitiative.org/our-reach |website=schistosomiasiscontrolinitiative.org |accessdate=12 March 2019}}</ref> || {{w|Burundi}}

|-

| 2010 || || Expansion || SCI begins working in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information">{{cite web |title=Schistosomiasis Control Initiative: Supplementary Information |url=https://www.givewell.org/charities/schistosomiasis-control-initiative/supplementary-information |website=givewell.org |accessdate=11 March 2019}}</ref> || {{w|Côte d'Ivoire}}

|-

| 2010 || October || Funding || SCI receives £10.5 million (plus separate funding for drugs) from the British {{w|Department for International Development}} for treating schistosomiasis and {{w|soil-transmitted helminthiasis}} in eight countries over five years.<ref>{{cite web |title=Imperial initiative to protect children from tropical disease awarded £25m government backing |url=http://www.imperial.ac.uk/news/93621/imperial-initiative-protect-children-from-tropical/ |website=imperial.ac.uk |accessdate=11 March 2019}}</ref><ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

|-

| 2010 || || Statistics || The {{w|World Health Organization}} reports that schistosomiasis mortality could be as high as 280,000 per year in {{w|Africa}} alone.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||

|-

| 2011 || || Expansion || SCI begins program in Liberia, Malawi, and Mozambique.<ref name="OUR REACH"/> || {{w|Liberia}}, {{w|Malawi}}, {{w|Mozanbique}}

|-

| 2012 || || Coverage || SCI reaches median coverage for schistosomiasis treatment at 77% in Malawi.<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd">{{cite web |title=SCHISTOSOMIASIS CONTROL INITIATIVE |url=https://www.givingwhatwecan.org/report/schistosomiasis-control-initiative/ |website=givingwhatwecan.org |accessdate=12 March 2019}}</ref> ||

|-

| 2013 || April || Coverage || SCI announces that it has facilitated delivery of its 100 millionth treatment of {{w|praziquantel}} against schistosomiasis thanks to funding from private donations.<ref name="SCIvv"/> ||

|-

| 2013 || || || A reported 261 million people require preventive chemotherapy for schistosomiasis worldwide, 92% of them living in {{w|sub-Saharan Africa}} and only 12.7% receiving preventive chemotherapy.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty">{{cite journal |last1=Savioli |first1=Lorenzo |last2=Albonico |first2=Marco |last3=Colley |first3=Daniel G. |last4=Correa-Oliveira |first4=Rodrigo |last5=Fenwick |first5=Alan |last6=Green |first6=Will |last7=Kabatereine |first7=Narcis |last8=Kabore |first8=Achille |last9=Katz |first9=Naftale |last10=Klohe |first10=Katharina |last11=LoVerde |first11=Philip T. |last12=Rollinson |first12=David |last13=Russell Stothard |first13=J. |last14=Tchuem Tchuenté |first14=Louis-Albert |last15=Waltz |first15=Johannes |last16=Zhou |first16=Xiao-Nong |title=Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty |doi=10.1186/s40249-017-0280-8 |pmid=28330495 |url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363045/ |pmc=5363045}}</ref> ||

|-

| 2013 – 2014 || Between November 2013 and April 2014 || || SCI funds mapping in {{w|Ethiopia}}.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Ethiopia}}

|-

| 2014 || || Expansion || SCI begins program in the Democratic Republic of the Congo and Madagascar.<ref name="OUR REACH"/> || {{w|Democratic Republic of the Congo}}, {{w|Madagascar}}

| 2014 || || Funding || The British {{w|Department for International Development}} awards SCI an additional £16.6 million over four and a half years (June 2014 to December 2018) to extend the program and expand it to an additional two countries.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

|-

|-

| 2014 – 2015 || || Coverage || SCI reports having delivered 3.1 million treatments in Côte d'Ivoire in the period.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> || {{w|Côte d'Ivoire}}

| 2015 || || Budget || SCI begins to use a system of country cashbooks for spending breakdown, which compare monthly in-country actual spending to budgets.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

|-

|-

| 2015 || || || {{w|Schistosomiasis}} is indicated to have the lowest level of preventive chemotherapy implementation in the spectrum of neglected tropical diseases. It is also highlighted as the disease most lacking in progress.<ref name="Building a global schistosomiasis alliance: an opportunity to join forces to fight inequality and rural poverty"/> ||

|-

| 2015 – 2016 || || Program || SCI plans to deliver around 0.6 million treatments and reports delivering 1.4 million treatments in Côte d'Ivoire.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

|-

| 2016 || January || Funding || {{w|Private foundation}} {{w|Good Ventures}} awards a grant of US$1,000,000 to the SCI for general operating support, in recognition of the organization’s earning a “top charity” ranking from {{w|GiveWell}} in 2015.<ref>{{cite web |title=Schistosomiasis Control Initiative — General Support (2016) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2016 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||

|-

| 2016 || August || Review || GiveWell estimates that programs supported by SCI can deworm a person for approximately US$1.26 based (including the estimated cost of SCI’s funding to country programs, SCI’s headquarters costs, cost of donated drugs, and local government involvement).<ref name="SCHISTOSOMIASIS CONTROL INITIATIVEd"/> ||

|-

| 2017 || January || Funding || Good Ventures awards a grant of US$13,500,000 to SCI for general operating support, in recognition of its earning a “top charity” ranking from GiveWell in 2016.<ref name="Schistosomiasis Control Initiative — General Support (2017)">{{cite web |title=Schistosomiasis Control Initiative — General Support (2017) |url=https://www.openphilanthropy.org/focus/global-health-and-development/miscellaneous/schistosomiasis-control-initiative-general-support-2017 |website=openphilanthropy.org |accessdate=11 March 2019}}</ref> ||

|-

| 2017 || October || Budget || SCI estimates that it would cost US$0.24 on average per additional treatment delivered to a school-aged child.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

|-

| 2017 || || Budget || GiveWell allocates 100% of its discretionary fund to the SCI in the fourth quarter of the year, totalling US$5.6 million.<ref name="HOW YOUR MONEY IS SPENT">{{cite web |title=HOW YOUR MONEY IS SPENT |url=https://www.schistosomiasiscontrolinitiative.org/how-money-is-spent |website=schistosomiasiscontrolinitiative.org |accessdate=15 March 2019}}</ref> ||

|-

|-

| 2019 || March || Funding || {{w|GiveWell}} updates its estimate of SCI's room for more funding from US$16.8 million to $28.7 million as a result of incorporating SCI's updates to its projections for how much funding it expects to receive from other funders over the next few years.<ref name="Schistosomiasis Control Initiative: Supplementary Information"/> ||

==See also==

==External links==